← Back to Screener
Bone Biologics Corp Common Stock (BBLG)
Price$1.25
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-24.68%
Price vs S&P 500 (4W)-5.03%
VGM Score33.65
Market Capitalization$2.24M
All Metrics
Book Value / Share (Quarterly)$2.60
P/TBV (Annual)0.35x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-1.43
Price vs S&P 500 (YTD)-22.04%
EPS (TTM)$-2.51
10-Day Avg Trading Volume0.02M
EPS Excl Extra (TTM)$-2.51
EPS (Annual)$-2.65
ROI (Annual)-57.81%
Cash / Share (Quarterly)$2.52
ROA (Last FY)-53.64%
EBITD / Share (TTM)$-2.02
ROE (5Y Avg)-106.62%
Cash Flow / Share (Annual)$-1.50
P/B Ratio0.48x
P/B Ratio (Quarterly)0.42x
Net Income / Employee (Annual)$-1,554,500
Net Interest Coverage (TTM)-0.99x
ROA (TTM)-47.38%
EPS Incl Extra (Annual)$-2.65
Current Ratio (Annual)13.85x
Quick Ratio (Quarterly)15.34x
3-Month Avg Trading Volume0.02M
52-Week Price Return-74.25%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$1.21
52-Week High$6.75
EPS Excl Extra (Annual)$-2.65
26-Week Price Return-16.75%
Quick Ratio (Annual)13.27x
13-Week Price Return2.35%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)16.09x
Enterprise Value$-2.29M
Revenue / Employee (Annual)$0
Cash / Share (Annual)$2.97
3-Month Return Std Dev42.48%
Net Income / Employee (TTM)$-1,428,900
ROE (Last FY)-57.81%
Net Interest Coverage (Annual)-1.01x
EPS Basic Excl Extra (Annual)$-2.65
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-2.51
ROI (TTM)-50.45%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$11.66
Price vs S&P 500 (52W)-98.62%
Year-to-Date Return-13.88%
5-Day Price Return-2.45%
EPS Normalized (Annual)$-2.65
ROA (5Y Avg)-88.21%
Month-to-Date Return-5.40%
EBITD / Share (Annual)$-2.75
ROI (5Y Avg)-106.62%
EPS Basic Excl Extra (TTM)$-2.51
P/TBV (Quarterly)0.54x
P/B Ratio (Annual)0.48x
Book Value / Share (Annual)$3.00
Price vs S&P 500 (13W)-5.90%
Beta0.57x
Revenue / Share (TTM)$0.00
ROE (TTM)-50.45%
52-Week Low$1.05
mGradeD
vgmGradeD
Show chart for
Earnings Surprise History
Q1 26-0.43est. -0.55
Analyst Recommendations
Aug 2023
Sep 2023
Oct 2023
Nov 2023
4.14
4.14
4.14
4.14
Industry Peers — Orthopedic & Prosthetic Devices(33)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
BBLGBone Biologics Corp Common Stock | — | — | D | $1.25 |
| ISRGIntuitive Surgical Inc. | F | B | C | $422.06 |
| EWEdwards Lifesciences Corp | D | C | C | $85.96 |
| STESTERIS plc | C | B | C | $212.35 |
| ZBHZimmer Biomet Holdings, Inc. | B | C | C | $87.33 |
| ALGNAlign Technology Inc | B | C | C | $167.74 |
| SNNSmith & Nephew plc | B | C | C | $30.61 |
| MSAMine Safety Incorporated | B | C | C | $161.30 |
| ESTAEstablishment Labs Holdings Inc. | F | A | B | $74.31 |
| ENOVEnovis Corporation | B | D | C | $23.78 |
| CDRECadre Holdings, Inc. | C | C | D | $30.01 |
About
Bone Biologics is a biotechnology company developing bone regeneration therapeutics. Its lead product, NELL-1, is a bone void filler designed for spinal, orthopedic, neurosurgery, and sports medicine procedures, with additional applications in plastic reconstruction and interventional radiology.